Table 1. Demographic and clinical characteristics of foreign-born, HIV-infected persons with and without parasite infections, 2009.
| Total (n = 128) | Infected with any parasite (n = 49) | Uninfected with any parasite (n = 79) | |
| Age in years, median (range) | 40 (19–64) | 40 (21–62) | 40 (19–64) |
| Male gender, N (%) | 86 (67) | 35 (71) | 51 (65) |
| Regions/Countries of Origin, N (%) | |||
| --Mexico | 48 (38) | 15 (31) | 33 (42) |
| --Africa | 40 (31) | 21 (43) | 19 (24) |
| ---- Western Africa | 18 (14) | 9 (18) | 9 (11) |
| ---- Eastern Africa | 14 (11) | 8 (16) | 6 (8) |
| ---- Southern Africa | 5 (4) | 2 (4) | 3 (4) |
| ---- Central Africa | 3 (2) | 2 (4) | 1 (1) |
| --Central America | 16 (13) | 7 (14) | 9 (11) |
| --Caribbean | 11 (9) | 2 (4) | 9 (11) |
| --Asia and Middle East | 7 (6) | 3 (6) | 4 (5) |
| --South America | 6 (5) | 1 (2) | 5 (6) |
| Years living in United States, median (range) | 10.8 (0.9–48.7) | 9.6 (1.3–35.6) | 11.1 (0.9–48.7) |
| Years since HIV diagnosis, median (range) | 5 (<1–21) | 5 (<1–15) | 5 (<1–21) |
| Years on cART, median (range) | 4 (<1–18) | 4 (<1–14) | 4 (<1–18) |
| On cART at time of the study, N (%)a | 112 (89) | 43 (88) | 69 (90) |
| CD4+ count (cells/mm3), median (range) | 307 (0–1757) | 194 (4–1159) | 308 (0–1757) |
| CD4+ nadir (cells/mm3), median (range) | 67 (0–982)b | 79 (2–982) | 64 (0–635) |
| Undetectable HIV VL, N (%)Detectable HIV VL (copies/ml), median (range)Eosinophil count (cells/mm3), median (range) | 95 (74)31,245(120–564,000)196 (31–2304) | 33 (67)18,800(120–529,000)264 (0–2304) | 62 (78)41,000(230–564,000)176 (34–924) |
| Eosinophilia >400 cells/mm3, n (%) | 25 (20) | 15 (31) | 10 (13) |
HIV, human immunodeficiency virus; cART, combination antiretroviral therapy; VL, viral load.
a
Data are missing for 2 persons.
b
Although CD4+ cell count nadirs of <200 cells/mm3 or an AIDS diagnosis are generally required for entry into the clinic, we did not have all prior laboratory test results; therefore, some reported nadirs are >200 cells/mm3.